Search Results
Results found for "Luke Pattison"
- 📢 GPCR Update: August 19-25, 2024 | Thrilling Announcement: New Pharmacology Course Dates & Exclusive Discounts Inside!
the GPR37-mTOR-S6K1 Signaling GPCRs in Neuroscience Astrocyte Gi-GPCR signaling corrects compulsive-like
- The sixth transmembrane region of a pheromone G-protein coupled receptor, Map3, is implicated in ...
Although such pheromone/receptor systems are likely to function in both mate choice and prezygotic isolation
- In vivo metabolic effects after acute activation of skeletal muscle G s signaling
Gs-coupled receptors enriched in SKM has only a limited impact on whole-body glucose homeostasis, most likely
- Do You Believe AI Could Accelerate Drug Discovery?
Moreover, advanced AI models like AlphaFold3, which can predict complex protein-molecule interactions
- Dynamic GPCR activation revealed through time-resolved Cryo-EM
This highlights the power of advanced imaging techniques like cryo-EM in solving complex biological puzzles
- How Schild Analysis Protects Your Conclusions in GPCR Research
Diagnose hidden effects like mixed receptor systems or slope deviations before they distort your interpretation
- How GPCR Collaboration Built an Innovation Engine
Most labs operated like small, competing startups.
- How to Design GPCR Drugs That Work in Vivo: Strategy, Tools, and Insights
That’s why we partner with innovators like Revvity , whose new reagent family— pHSense™ —isn’t just another
- GPCR Drug Discovery at Discovery on Target: Why This Track Is About More Than Receptors
Hearing Terry speak is more than an academic experience — it’s like being handed a new set of tools to
- Feeder or trigger – CCR2 as a scavenger and regulator of cell migration
CCR2 was also shown to be resistant to degradation and most likely recycling through the trans-Golgi D’Amico et. al 2000), becoming incapable of promoting cell migration, a phenomenon which is likely to
- Overview of adhesion GPCRs self-activation
Structurally they characterize by a long extracellular region of adhesion-like domains which modulate possible to know that ADGRL3 can activate and form stable complexes with Gs, Gi, Gq, and G12, where like
- 📰 GPCR Weekly News, October 9 to 15, 2023
low relatedness Industry News Nobel Laureates Highlight Symposium Celebrating Lefkowitz’s 50 Years at Duke
- 📰 GPCR Weekly News, June 12 to 18, 2023
But before we delve into the latest news, we'd like to highlight some upcoming events and resources:
- The Perils and Guardrails of Modifying Signalling Proteins in Bioassays
Given the sensitive allosteric nature of GPCRs with their binding partners, tags or modifications are likely able to detect interaction with the strongest coupling partner Gαs (Figure 2A), and for the glucagon-like-peptide Manchanda and colleagues [37] showed that for the glucagon-like-peptide-1 receptor (GLP-1R), mini-Gs inhibited β-arrestin recruitment, receptor internalisation, and endosomal trafficking for the glucagon-like-peptide
- 📰 GPCR Weekly News, May 15 to 21, 2023
If you are interested in giving a talk, contact us at Hello@DrGPCR.com, and if you would like to present
- Targeted Drug Design through GPCR Mutagenesis: Insights from β2AR
the evolutionary conservation of these residues can lead to the development of drugs that are less likely
- Interacting binding insights and conformational consequences of the differential activity of...
contrast, when the GPR55 receptor is simulated in complex with the selective agonist ML186, agonist-like
- 📰 GPCR Weekly News, October 23 to 29, 2023
cell mobilization when combined with propranolol Discovery of 3-Phenyl Indazole-Based Novel Chemokine-like
- Self-docking and cross-docking simulations of G protein-coupled receptor-ligand complexes
conformational sampling in advance of docking or receptor conformational adjustment after docking are more likely
- The Truth About GPCR Product Launches: Years in the Making
GPCR X Revvity Collaboration ⸻ Want more like this? 👉 Join the Dr.
- How a Failed Med School Dream Sparked a GPCR Biotech Revolution
that slow down or prevent good science from reaching patients — particularly in underfunded fields like
- Understanding the Journey: Catherine Demery's Path to Addiction Science
excelling in the PCAT and gaining admission to pharmacy school at the University of Michigan, it seemed like
- 📰 GPCR Weekly News, April 1 to 7, 2024
If you have any research you would like to showcase to our community, you can submit a poster presentation
- 📰 GPCR Weekly News, January 16 to 22, 2023
Revealing the tissue-level complexity of endogenous glucagon-like peptide-1 receptor expression and signaling
- Artificial intelligence – faster, smarter, cheaper GPCR drug discovery
Efforts will likely be made to develop AI models that can provide transparent explanations for their The sharing and collaboration of data across academia, industry, and regulatory bodies will likely increase
- Orthosteric vs. Allosteric Interactions: The Silent Decider of Safety and Success
Allosterics , in contrast, act more like tuning knobs—modulating receptor ensembles in partnership with
- Targeting GPCRs in the CNS: Advances in Drug Discovery Strategies
Depending on the type of GPCR, it can lead to different secondary messengers , like cAMP, IP3, which
- Why Opposing Processes Matter for Your Next GPCR Drug
The same compound can look like an activator in one system and a blocker in another—depending on basal
- 📰 GPCR Buzz: August 5-11, 2024 | Top Highlights from DrGPCR University!
protein signalling and modulates excitability of human induced pluripotent stem cell-derived nociceptive-like
- How Advanced GPCR Kinetics Sharpen Decision Making (and Save You Time)
Gives You an Edge Premium delivers curated, noise-free intelligence every week: expert frameworks (like

















